2 Top Managers on Secular Change and the Market
T. Rowe Price's David Giroux and Wellington Management's Jean Hynes talk value investing, innovation in healthcare, and where they're finding opportunity.
A recurring theme at the conference was: Will value investing ever rebound? Is a reversion to the mean forthcoming or has the market fundamentally changed during the past decade?
Morningstar's director of equity strategies Katie Reichart posed those questions--and many others--to two fund managers who've proved adept at valuing companies relative to their growth prospects: Giroux, who manages Gold-rated T. Rowe Price Capital Appreciation (PRWCX), and Hynes, who leads Gold-rated Vanguard Health Care (VGHCX).
Susan Dziubinski does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.